We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 4,305 results
  1. Relationship between heart failure and intestinal inflammation in infants with congenital heart disease

    Objective

    The association between heart failure (HF) and intestinal inflammation caused by a disturbed intestinal microbiota in infants with...

    Qi-Liang Zhang, **u-Hua Chen, ... Hua Cao in BMC Microbiology
    Article Open access 25 March 2024
  2. Association between placental DNA methylation and fetal congenital heart disease

    Congenital heart disease (CHD) is a worldwide problem with high morbidity and mortality. Early diagnosis of congenital heart disease is still a...

    **g**g Liu, Yuduo Wu, ... Yihua He in Molecular Genetics and Genomics
    Article 17 November 2022
  3. Congenital Heart Defects Which Include Cardiac Valve Abnormalities

    Atrioventricular or semilunar valve disease can be an isolated congenital heart abnormality, but may also occur as part of a more complex congenital...
    Massimo Griselli, Rebecca K. Ameduri, Michael L. Rigby in Heart Valves
    Chapter 2023
  4. Gene editing and cardiac disease modelling for the interpretation of genetic variants of uncertain significance in congenital heart disease

    Background

    Genomic sequencing in congenital heart disease (CHD) patients often discovers novel genetic variants, which are classified as variants of...

    Vanessa S. Fear, Catherine A. Forbes, ... Timo Lassmann in Stem Cell Research & Therapy
    Article Open access 05 December 2023
  5. Current advances in human-induced pluripotent stem cell-based models and therapeutic approaches for congenital heart disease

    Congenital heart disease (CHD) represents a significant risk factor with profound implications for neonatal survival rates and the overall well-being...

    Meiling Cao, Yanshan Liu, ... Hongkun Jiang in Molecular and Cellular Biochemistry
    Article 18 April 2024
  6. Functional screening of congenital heart disease risk loci identifies 5 genes essential for heart development in zebrafish

    Congenital heart disease (CHD) is the most common birth defect worldwide and a main cause of perinatal and infant mortality. Our previous genome-wide...

    Jianlong Ma, Yayun Gu, ... Mingxi Liu in Cellular and Molecular Life Sciences
    Article 27 December 2022
  7. Plasma metabolomic and lipidomic profiles accurately classify mothers of children with congenital heart disease: an observational study

    Introduction

    Congenital heart disease (CHD) is the most common congenital anomaly, representing a significant global disease burden. Limitations exist...

    Stuart Mires, Eduardo Sommella, ... Massimo Caputo in Metabolomics
    Article Open access 02 July 2024
  8. Copy number variation-associated lncRNAs may contribute to the etiologies of congenital heart disease

    Copy number variations (CNVs) have long been recognized as pathogenic factors for congenital heart disease (CHD). Few CHD associated CNVs could be...

    Yibo Lu, Qing Fang, ... Bo Wang in Communications Biology
    Article Open access 17 February 2023
  9. Deep sequencing unveils altered cardiac miRNome in congenital heart disease

    Abstract

    Congenital heart disease (CHD) surges from fetal cardiac dysmorphogenesis and chiefly contributes to perinatal morbidity and cardiovascular...

    Vinu Ramachandran, Sambhavi Bhagavatheeswaran, ... Anandan Balakrishnan in Molecular Genetics and Genomics
    Article 07 June 2022
  10. Heart Valve Disease

    This chapter was designed to provide the reader with a brief overview of the current treatment options for human heart valve disease. Major topics of...
    Ranjit John, Chesney Siems in Heart Valves
    Chapter 2023
  11. Matched comparison of decellularized homografts and bovine jugular vein conduits for pulmonary valve replacement in congenital heart disease

    For decades, bovine jugular vein conduits (BJV) and classic cryopreserved homografts have been the two most widely used options for pulmonary valve...

    Dmitry Bobylev, Alexander Horke, ... Samir Sarikouch in Cell and Tissue Banking
    Article Open access 14 March 2023
  12. Novel and deleterious nucleotide variations in the HAND1 gene probably affect miRNA target sites and protein function in pediatric patients with congenital heart disease

    Background

    Congenital heart disease (CHD) is the most prevalent developmental defect and principal cause of infant mortality and affects cardiac and...

    Fateme Tabrizi, Mehri Khatami, ... Mohammad Ali Navabi Shirazi in Molecular Biology Reports
    Article 29 March 2024
  13. Incidence, distribution, disease spectrum, and genetic deficits of congenital heart defects in China: implementation of prenatal ultrasound screening identified 18,171 affected fetuses from 2,452,249 pregnancies

    Background

    Congenital heart defects (CHDs) are the most common birth defects. Assessment of the incidence, distribution, disease spectrum, and genetic...

    **nlin Chen, Sheng Zhao, ... Nanbert Zhong in Cell & Bioscience
    Article Open access 19 December 2023
  14. Gene-Interaction-Sensitive enrichment analysis in congenital heart disease

    Background

    Gene set enrichment analysis (GSEA) uses gene-level univariate associations to identify gene set-phenotype associations for hypothesis...

    Alexa A. Woodward, Deanne M. Taylor, ... Ryan J. Urbanowicz in BioData Mining
    Article Open access 12 February 2022
  15. High throughput mutation screening of cardiac transcription factor GATA4 among Tanzania children with congenital heart diseases

    Congenital heart disorders (CHDs) are common, estimated to affect 8 out of every 1000 live births, and they are associated with high mortality and...

    Emmanuel Suluba, James Masaganya, ... Liu Shuwei in The Nucleus
    Article 04 January 2023
  16. Preservation of human heart valves for replacement in children with heart valve disease: past, present and future

    Valvular heart disease affects 30% of the new-borns with congenital heart disease. Valve replacement of semilunar valves by mechanical, bioprosthetic...

    M. C. Peters, B. P. T. Kruithof, ... A. van Wijk in Cell and Tissue Banking
    Article Open access 01 February 2023
  17. Extensive identification of genes involved in congenital and structural heart disorders and cardiomyopathy

    Clinical presentation of congenital heart disease is heterogeneous, making identification of the disease-causing genes and their genetic pathways and...

    Nadine Spielmann, Gregor Miller, ... Martin Hrabe de Angelis in Nature Cardiovascular Research
    Article Open access 17 February 2022
  18. Modulation of cAMP/cGMP signaling as prevention of congenital heart defects in Pde2A deficient embryos: a matter of oxidative stress

    Phosphodiesterase 2A (Pde2A) is a dual-specific PDE that breaks down both cAMP and cGMP cyclic nucleotides. We recently highlighted a direct...

    Silvia Cardarelli, Martina Biglietto, ... Manuela Pellegrini in Cell Death & Disease
    Article Open access 23 February 2024
  19. Genome-wide association studies highlight novel risk loci for septal defects and left-sided congenital heart defects

    Background

    Congenital heart defects (CHD) are structural defects of the heart affecting approximately 1% of newborns. They exhibit low penetrance and...

    Martin Broberg, Minna Ampuja, ... Emmi Helle in BMC Genomics
    Article Open access 07 March 2024
Did you find what you were looking for? Share feedback.